Body weight reduction in rats by oral treatment with zinc plus cyclo-(His-Pro)

British Journal of Pharmacology

Volumn 158, Issue 2, 2009, Pages 442-450

  Song, M K ^a,b   Rosenthal, M J ^a,b   Song, A M ^c   Uyemura, K ^a,b   Yang, H ^a,b   Ament, M E ^a   Yamaguchi, D T ^a,b   Cornford, E M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^c KAISER PERMANENTE MEDICAL CENTER   (United States)

Author keywords

Adiponectin; Cyclo (His Pro); Diabetic G K rats; Insulin degrading enzyme; Leptin; Obese S D rats; Zinc

Indexed keywords

CYCLO(HISTIDYLPROLINE); EQUAL; GLUCOSE; INSULIN; SUCROSE; SWEETENING AGENT; UNCLASSIFIED DRUG; ZINC; ZINC CYCLO(HISTIDYLPROLINE); ZINC DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CARBOHYDRATE INTAKE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE MODEL; DRUG MECHANISM; FOOD INTAKE; GOTO KAKIZAKI RAT; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; TASTE AVERSION; TREATMENT OUTCOME; WEIGHT REDUCTION; ZINC DEFICIENCY;

ADIPONECTIN; ADMINISTRATION, ORAL; AGE FACTORS; ANIMALS; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DRUG THERAPY, COMBINATION; FEMALE; LEPTIN; MALE; OBESITY; PEPTIDES, CYCLIC; PIPERAZINES; RATS; RATS, SPRAGUE-DAWLEY; ZINC;

EID: 69549138180     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2009.00201.x     Document Type: Article

References (50)

1. Benzi L, Ciccarone AM, Cecchetti P, DiCianni G, Caricato F, Trincavelli L et al. (1999). Intracellular hyperinsulinemia: a metabolic characteristic of obesity with and without type 2 daibetes intracellular insulin in obesity and type 2 diabetes. Diabetes Res Clin Pract 46 : 231 237.
2. Bluher M, Bullen JW, Lee JH, Kralish S, Fasshauer M, Kloting N et al. (2006). Circulating adiponectin and expression of adiponectin receptors in human skeletal muscle: association with metabolic parameters and insulin resistance and regulated by physical training. J Clin Endocrinol Metab 91 : 2310 2316.
3. Bock BC, Kanarek RB, Aprille JR (1995). Mineral content of the diet alters sucrose induced obesity in rats. Physiol Behav 57 : 659 668.
4. Borza DB, Morgan WT (1998). Histidine-proline-rich glycoprotein as plasma pH sensor. J Biol Chem 273 : 5493 5499.
5. Bouchard C, Trembaly A, Despress JP, Nadeau A, Lupien PJ, Theeriault G et al. (1990). The response to long-term overfeeding in identical twins. N Engl J Med 322 : 1477 1482.
6. Chen MD, Lin PY (2000). Zinc-induced hyperleptinemia relates to the amelioration of sucrose-induced obesity with zinc repletion. Obes Res 8 : 525 529.
7. Chen MD, Lin PY, Lin WH, Cheng V (1988). Zinc in hair and serum of obese individuals in Taiwan. Am J Clin Nutr 48 : 1307 1309.
8. Chen MD, Liou SJ, Lin PY, Yang VC, Alexanders PS, Lin WH (1998). Effects of zinc supplementation on the plasma glucose level and insulin activity in genetically obese (ob/ob) mice. Biol Trace Elem Res 61 : 303 311.
9. Dess NK (1993). Saccharin's aversive taste in rats: evidence and implications. Neurosci Biobehav Rev 17 : 359 372.
10. Di Martino G, Matera MG, De Martino B, Vacca C, Di Martino S, Rossi F (1993). Relationship between zinc and obesity. J Med 24 : 177 183.
11. Escriva F, Gavete ML, Fermin Y, Perez Z, Gallardo N, Alvarez C et al. (2007). Effect of age and moderate food restriction on insulin sensitivity in Wistar rats: role of adiposity. J Endocrinol 194 : 131 141.
12. Fried SK, Russell CD (1977). Diverse roles of adipose tissue in the regulation of systemic metabolism and energy balance. In : Bray GA, Bouchard C, James WP (eds). Handbook of Obesity. Marcel Dekker : New York, pp. 397 414.
13. Gallou-Kabani C, Vige A, Gross MS, Rabes JP, Bolleau C, Larue-Achagiotis C et al. (2007). C57BL/6J and A/J mice fed a high-fat diet delineate components of metabolic syndrome. Obesity 15 : 1996 2005.
14. Gannage-Yared MH, Khalife S, Semaan M, Fares F, Jambart S, Halaby G (2006). Serum adiponectin and leptin levels in relation to the metabolic syndrome, androgenic profile and somatotrophic axis in healthy non-diabetic elderly man. Eur J Endocrinol 155 : 167 176.
15. Hamel FG, Upward JI, Bennett RG (2003). In vitro inhibition of insulin-degrading enzyme by long-chain fatty acids and their coenzyme a thioesters. Endocrinology 144 : 2404 2408.
16. Huang W, Dedousis N, Bhatt BA, O'Doberty RM (2004). Impaired activation of phosphatidylinositol 3-kinase by leptin is a novel mechanisms of hepatic leptin resistance in diet-induced obesity. J Biol Chem 279 : 21695 21700.
17. Huang W, Dedousis N, O'Doberty RM (2007). Hepatic steatosis and plasma dyslipidemia induced by a high-sucrose diet are corrected by an acute leptin infusion. J Appl Physiol 102 : 2260 2265.
18. Huber AM, Gershoff SN (1973). Effect of zinc deficiency in rats on insulin release from the pancreas. J Nutr 103 : 1739 1744.
19. Hwang IK, Go VL, Harris DM, Yip I, Kang KW, Song MK (2003). Effects of cyclo (his-pro) plus zinc on glucose metabolism in genetically diabetic obese mice. Diabet Obes Metab 5 : 317 324. (Pubitemid 37138862)
20. Ishihara H, Mori M, Kobayashi I, Kobayashi S (1985). Intraventricular administration of cyclo (his-pro), metabolite of thryrotrophin-releasing hormone (TRH), decreases water intake in the rat. Proc Soc Exp Biol Med 178 : 623 628.
21. Jikihara H, Ikegami H, Koike K, Wada K, Morishige K, Kurachi H et al. (1993). Intraventricular administration of histidyl-proline diketopeparazine [Cyclo(his-pro)] suppresses prolactin secretion and synthesis: a possible role of Cyclo (his-pro) as dopamine uptake blocker in rat hypothalamus. Endocrinology 132 : 953 958.
22. Jimenez J, Zuniga-Guajardo S, Zinman B, Angel A (1987). Effects of weight loss in massive obesity on insulin and C-peptide dynamics: sequential changes in insulin production, clearance, and sensitivity. J Clin Endocrinol Metab 64 : 661 668.
23. Kagabu Y, Mishiba T, Okino T, Yanagisawa T (1998). Effects of thyrotropin-releasing hormone and its metabolites, Cyclo(his-pro) and TRH-OH, on growth hormone and prolactin synthesis in primary cultured pituitary cells of the common carp, Cyprinus carpio. Gen Comp Endocrinol 111 : 395 403.
24. Kambe T, Yamaguchi-Iwai Y, Sasaki R, Nagao M (2004). Overview of mammalian zinc transporters. Cell Mol Life Sci 61 : 49 68.
25. Kelly EJ, Quaife CJ, Froelick GJ, Palmiter RD (1996). Metallothionein I and II protect against zinc deficiency and zinc toxicity in mice. J Nutr 126 : 1782 1790.
26. Kow LM, Pfaff DW (1991). Cyclo (his-pro) potentiates the reduction of food intake induced by amphetamine, fenfluramine, or serotonin. Pharamcol Biochem Behav 38 : 365 369.
27. Levenson CW (2003). Zinc regulation of food intake: new insights on the role of neuropeptide Y. Nutr Rev 61 : 247 249.
28. Mangian HF, Lee RG, Paul GL, Emmert JL, Shay NF (1998). Zinc deficiency suppresses plasma leptin concentration in rats. J Nutr Biochem 9 : 47 51.
29. Mantzoro CS, Prasad AS, Beck FWJ, Crabowski S, Kaplan J, Adair C et al. (1998). Zinc may regulate serum leptin concentrations in humans. J Am Coll Nutr 17 : 270 275.
30. Meistas MT, Margolis S, Kowarski AA (1983). Hyperinsulinemia of obesity is due to decreased clearance of insulin. Am J Physiol Endocrinol Metab 245 : E155 E159.
31. Mora MEV, Scarfone A, Calvani M, Grecco AV (2003). Insulin clearance in obesity. J Am coll Nutr 22 : 487 493.
32. Morgan WT (1978). Human serum histidine-proline-rich glycoprotein. Biochim Biophys Acta 533 : 319 333.
33. Morley JE, Levine AS, Prasad C (1981). Histidyl-proline diketopiperazine decreases food intake in rats. Brain Res 210 : 475 478.
34. Ott ES, Shay NF (2001). Zinc deficiency reduces leptin gene expression and leptin in rat adipocytes. Exp Biol Med 226 : 841 846.
35. Ozata M, Mergen M, Oktenli C, Aydin A, Sanisoglu SY, Bolu E et al. (2002). Increased oxidative stress and hypozincemia in male obesity. Clin Biochem 35 : 627 631.
36. Perlman RK, Rosner MR (1994). Identification of zinc ligands of the insulin degrading enzyme. J Biol Chem 269 : 33140 33145.
37. Pocai A, Morgan K, Buettner C, Gutierrez-Juarez R, Obici S, Rossetti L (2005). Central leptin acutely reverses diet-induced hepatic insulin resistance. Diabetes 54 : 3182 3189.
38. Prasad C (1988). Cyclo (His-Pro): its distribution, origin and function in the human. Neurosci Biobehav Rev 12 : 19 22.
39. Prasad C, Mizuma H, Brock JW, Porter JR, Svec F, Hilton C (1995). A paradoxical elevation of brain cyclo (his-pro) levels in hyperphagic obese Zucker rats. Brain Res 699 : 149 153.
40. Rosenthal MJ, Hwang IK, Song MK (2003). Effects of arachidonic acid and cyclo(his-pro) on zinc transport across small intestine and muscle tissues. Life Sci 70 : 337 348.
41. Scarpace PJ, Tumer N (2001). Peripheral and hypothalamic leptin resistance with age-related obesity. Physiol Behav 74 : 721 727.
42. Song MK, Hwang IK, Rosenthal MJ, Harris DM, Yamaguchi DT, Yip I et al. (2003). Anti-hyperglycemic activity of zinc plus cyclo (his-pro) in genetically diabetic Goto-Kakizaki and aged rats. Exp Biol Med 228 : 1338 1345. (Pubitemid 37549238)
43. Stefan M, Nicholls RD (2005). What have rare genetic syndromes taught us about the pathophysiology of the common forms of obesity? Curr Diab Rep 4 : 143 150.
44. Takita S, Wakamoto Y, Kunitsugu I, Sugiyama S, Okuda M, Houbara T (2004). Altered tissue concentration of mineral in spontaneousl diabetic rats (Goto-Kakizaki rats). J Toxicol Sci 29 : 195 199.
45. Taneja SK, Mahajan M, Arya P (1996). Excess bioavailability of zinc may cause obesity in humans. Experientia 52 : 31 33.
46. Tungtrongchitr R, Pongpaew P, Phonrat B, Tungtrongchitr A, Viroonudomphol D, Vudhivai N et al. (2003). Serum copper, zinc, ceruloplasmin and superoxide dismutase in Thai overweight and obese. J Med Assoc Thai 86 : 543 551.
47. Vona-Davis L, Howard-McNatt M, Rose DP (2007). Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer. Obes Rev 8 : 395 408.
48. Yakinci C, Pac A, Kucukbay FZ, Tayfun M, Gul A (1997). Serum zinc, copper, and magnesium levels in obese children. Acta Pediatr Jpn 39 : 339 341.
49. Yamada M, Wilber JF (1989). The distribution of histidyl-proline diketopiperazine [cyclo(His-Pro)] in discrete rat hypothalamic nuclei. Neuropeptides 13 : 221 223.
50. Yildiz BO, Haznedaroglu IC (2005). Rethinking leptin and insulin action: therapeutic opportunities for diabetes. Int J Biochem Cell Biol 38 : 820 830.